Artificial Intelligence-Based Object Recognition Automates
Manual Tasks and Data Collection to Optimize Operating Room
Workflow Efficiency
WARSAW,
Ind., May 10, 2022 /PRNewswire/ -- Zimmer Biomet
Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology
leader, today introduced the availability of new artificial
intelligence¹ (AI) capabilities within
Omni™ Suite, an intelligent operating room (OR)
designed to optimize surgical workflow and procedural efficiency by
automating manual tasks and streamlining unnecessary technology and
redundant hardware. The new AI feature uses cameras to
automatically recognize and timestamp key OR workflow milestones,
including patient entry and exit, door count, the start and stop of
anesthesia, surgery and cleaning. Surgical teams are guided through
a process to help optimize OR workflow based on real-time access to
workflow metrics.
"Omni Suite is more than just another manual integration
solution – it is a smart system designed to work with OR staff
throughout the procedure," said Robert Kraal, Vice President and
General Manager, Connected Health at Zimmer Biomet. "Now, with this
new feature, surgical teams can utilize and rely on Omni Suite's AI
capabilities to optimize OR workflow. By providing data points that
have been historically captured manually, if at all, surgical teams
can improve OR workflow and minimize manual activities, allowing
more time for patient care."
Omni Suite's AI feature further expands the AI capabilities of
ZBEdge™, a suite of integrated smart, digital and robotic
technologies designed to deliver transformative data-powered
clinical insights with the goal of improving patient outcomes. Last
month, ZBEdge added powerful predictive analytics capabilities with
WalkAI™, an AI model to predict post-operative gait (walking) speed
recovery progress after hip or knee surgery.
"Omni Suite's latest feature further enhances the value and
utility of the Omni Suite platform while adding AI capabilities to
strengthen our ZBEdge Connected Intelligence Suite," said Ivan
Tornos, Chief Operating Officer, Zimmer Biomet. "Omni Suite, along
with the smart, digital and robotic solutions that make up ZBEdge,
allow us to create value innovation that unlocks data-driven
insights to enhance the surgical experience for surgeons, care
teams and patients."
Omni Suite's AI feature is now available in the United States. For more information on
Omni Suite's AI offerings, visit
https://www.zimmerbiomet.com/en/products-and-solutions/specialties/intelligent-integration.html.
About the Company
Zimmer Biomet is a global medical
technology leader with a comprehensive portfolio designed to
maximize mobility and improve health. We seamlessly transform the
patient experience through our innovative products and suite of
integrated digital and robotic technologies that leverage data,
data analytics and artificial intelligence.
With 90+ years of trusted leadership and proven expertise,
Zimmer Biomet is positioned to deliver the highest quality
solutions to patients and providers. Our legacy continues to come
to life today through our progressive culture of evolution and
innovation.
For more information about our product portfolio, our operations
in 25+ countries and sales in 100+ countries or about joining our
team, visit www.zimmerbiomet.com or follow Zimmer Biomet on Twitter
at www.twitter.com/zimmerbiomet.
Cautionary Statement Regarding Forward-Looking
Statements
This news release contains forward-looking
statements within the meaning of the safe harbor provisions of the
Private Securities Litigation Reform Act of
1995. Forward-looking statements include, but are not limited
to, statements concerning Zimmer Biomet's expectations, plans,
prospects, and product and service offerings, including new product
launches and potential clinical successes. Such statements are
based upon the current beliefs and expectations of management and
are subject to significant risks, uncertainties and changes in
circumstances that could cause actual outcomes and results to
differ materially. For a list and description of some of such
risks and uncertainties, see Zimmer Biomet's periodic reports filed
with the U.S. Securities and Exchange Commission
(SEC). These factors should not be construed as exhaustive and
should be read in conjunction with the other cautionary statements
that are included in Zimmer Biomet's filings with the
SEC. Forward-looking statements speak only as of the date they
are made, and Zimmer Biomet disclaims any intention or obligation
to update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise. Readers
of this news release are cautioned not to rely on these
forward-looking statements, since there can be no assurance that
these forward-looking statements will prove to be
accurate. This cautionary statement is applicable to all
forward-looking statements contained in this news release.
¹ The AI was developed to support the existing administrative
tasks to enhance the efficiency of the OR workflow. The AI does not
function to support any clinical decisions.
Media
|
|
Meredith
Weissman
|
|
(703) 346-3127
|
|
meredith.weissman@zimmerbiomet.com
|
|
|
|
Investors
|
|
Ezgi Yagci
|
Keri Mattox
|
(617) 549-2443
|
(203)
399-0856
|
ezgi.yagci@zimmerbiomet.com
|
keri.mattox@zimmerbiomet.com
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/zimmer-biomet-debuts-first-of-its-kind-artificial-intelligence-capabilities-for-omni-suite-intelligent-operating-room-301543149.html
SOURCE Zimmer Biomet Holdings, Inc.